Cefprozil

Product NDC: 0781-6203
11-digit product format: 007816203
Labeler code: 0781
Product ID: 0781-6203_4272315e-8350-44d3-ab67-49488f766f61
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Cefprozil
Dosage form: POWDER, FOR SUSPENSION
Route: ORAL
Labeler: Sandoz Inc
Application: ANDA065257
Marketing category: ANDA
Marketing start: 2005-12-05
Marketing end: 0000-00-00
Substance: CEFPROZIL
Active strength: 250 mg/5mL
NDC exclude flag: No
Listing certified through: 2019-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 4 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	0781-6203		D	Discontinued by firm	2026-08-17
excluded package	package	0781-6203	0781-6203-46	D	Discontinued by firm	2026-08-17
excluded package	package	0781-6203	0781-6203-57	D	Discontinued by firm	2026-08-17
excluded package	package	0781-6203	0781-6203-91	D	Discontinued by firm	2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 48 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0781-6203-57	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0781-6203-91	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0781-6203-46	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0781-6203-57	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0781-6203-91	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0781-6203-46	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0781-6203-57	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0781-6203-91	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0781-6203-46	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0781-6203-57	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0781-6203-91	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0781-6203-46	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0781-6203-57	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0781-6203-91	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0781-6203-46	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0781-6203-57	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0781-6203-91	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0781-6203-46	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0781-6203-57	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0781-6203-91	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0781-6203-46	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0781-6203-57	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0781-6203-91	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0781-6203-46	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0781-6203-57	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0781-6203-91	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0781-6203-46	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0781-6203-57	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0781-6203-91	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0781-6203-46	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0781-6203-57	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0781-6203-91	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0781-6203-46	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0781-6203-57	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0781-6203-91	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0781-6203-46	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A065257-001	CEFPROZIL	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL			2005-12-08
A065257-002	CEFPROZIL	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL			2005-12-08

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A065257-001	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL		2005-12-08	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A065257-002	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL		2005-12-08	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A065257-001	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL		2005-12-08	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065257-002	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL		2005-12-08	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065257-001	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL		2005-12-08	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065257-002	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL		2005-12-08	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065257-001	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL		2005-12-08	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065257-002	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL		2005-12-08	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065257-001	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL		2005-12-08	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065257-002	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL		2005-12-08	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065257-001	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL		2005-12-08	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065257-002	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL		2005-12-08	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065257-001	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL		2005-12-08	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065257-002	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL		2005-12-08	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065257-001	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL		2005-12-08	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065257-002	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL		2005-12-08	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065257-001	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL		2005-12-08	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065257-002	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL		2005-12-08	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065257-001	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL		2005-12-08	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065257-002	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL		2005-12-08	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065257-001	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL		2005-12-08	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065257-002	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL		2005-12-08	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065257-001	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL		2005-12-08	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065257-002	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL		2005-12-08	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065257-001	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL		2005-12-08	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065257-002	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL		2005-12-08	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065257-001	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL		2005-12-08	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065257-002	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL		2005-12-08	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A065257-001	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL		2005-12-08	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A065257-002	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL		2005-12-08	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065257-001	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL	AB	2005-12-08	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065257-002	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL	AB	2005-12-08	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A065257-001	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL	AB	2005-12-08	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A065257-002	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL	AB	2005-12-08	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065257-001	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL	AB	2005-12-08	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A065257-002	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL	AB	2005-12-08	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065257-001	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL	AB	2005-12-08	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A065257-002	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL	AB	2005-12-08	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A065257-001	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL	AB	2005-12-08	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A065257-002	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL	AB	2005-12-08	`bb7c543d1eb4…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065257-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065257-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A065257-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A065257-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065257-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A065257-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065257-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A065257-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A065257-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A065257-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A065257-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A065257-002	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A065257-001	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A065257-002	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A065257-001	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	A065257-002	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A065257-001	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A065257-002	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A065257-001	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A065257-002	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A065257-001	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A065257-002	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A065257-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A065257-002	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A065257-001	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A065257-002	AB	1	`ea99ee380514…`
2022-10-28 04:53 UTC	2022-10	A065257-001	AB	1	`f41ea6bd6efb…`
2022-10-28 04:53 UTC	2022-10	A065257-002	AB	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A065257-001	AB	1	`e64feba35796…`
2022-09-29 23:25 UTC	2022-09	A065257-002	AB	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A065257-001	AB	1	`cb3db0bc1861…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A065257-002	AB	1	`cb3db0bc1861…`

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0781-6203-46	ML - Milliliter	0781-6203	2eb9ad78-4572-4af2-9840-1ce4ecb7a91c	1	2013-02-13
0781-6203-57	ML - Milliliter	0781-6203	c97a15a6-accc-4a6f-b39f-2a7eaffdc62b	1	2013-02-13
0781-6203-91	ML - Milliliter	0781-6203	c9a2fdb8-e662-47a3-851f-76423e16cd21	1	2013-02-13

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CEFPROZIL	ACTIVE INGREDIENT	4W0459ZA4V	CEFPROZIL TABLET, FILM COATED CEFPROZIL POWDER, FOR SUSPENSION [SANDOZ INC]	11
CEFPROZIL ANHYDROUS	ACTIVE MOIETY	1M698F4H4E	CEFPROZIL TABLET, FILM COATED CEFPROZIL POWDER, FOR SUSPENSION [SANDOZ INC]	11
.ALPHA.-TOCOPHEROL, DL-	INACTIVE INGREDIENT	7QWA1RIO01	CEFPROZIL TABLET, FILM COATED CEFPROZIL POWDER, FOR SUSPENSION [SANDOZ INC]	11
ANHYDROUS CITRIC ACID	INACTIVE INGREDIENT	XF417D3PSL	CEFPROZIL TABLET, FILM COATED CEFPROZIL POWDER, FOR SUSPENSION [SANDOZ INC]	11
ASPARTAME	INACTIVE INGREDIENT	Z0H242BBR1	CEFPROZIL TABLET, FILM COATED CEFPROZIL POWDER, FOR SUSPENSION [SANDOZ INC]	11
BENZYL ALCOHOL	INACTIVE INGREDIENT	LKG8494WBH	CEFPROZIL TABLET, FILM COATED CEFPROZIL POWDER, FOR SUSPENSION [SANDOZ INC]	11
CARBOXYMETHYLCELLULOSE SODIUM	INACTIVE INGREDIENT	K679OBS311	CEFPROZIL TABLET, FILM COATED CEFPROZIL POWDER, FOR SUSPENSION [SANDOZ INC]	11
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	CEFPROZIL TABLET, FILM COATED CEFPROZIL POWDER, FOR SUSPENSION [SANDOZ INC]	11
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	CEFPROZIL TABLET, FILM COATED CEFPROZIL POWDER, FOR SUSPENSION [SANDOZ INC]	11
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	CEFPROZIL TABLET, FILM COATED CEFPROZIL POWDER, FOR SUSPENSION [SANDOZ INC]	11
GLYCINE	INACTIVE INGREDIENT	TE7660XO1C	CEFPROZIL TABLET, FILM COATED CEFPROZIL POWDER, FOR SUSPENSION [SANDOZ INC]	11
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	CEFPROZIL TABLET, FILM COATED CEFPROZIL POWDER, FOR SUSPENSION [SANDOZ INC]	11
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CEFPROZIL TABLET, FILM COATED CEFPROZIL POWDER, FOR SUSPENSION [SANDOZ INC]	11
MALTODEXTRIN	INACTIVE INGREDIENT	7CVR7L4A2D	CEFPROZIL TABLET, FILM COATED CEFPROZIL POWDER, FOR SUSPENSION [SANDOZ INC]	11
METHYLCELLULOSE (400 MPA.S)	INACTIVE INGREDIENT	O0GN6F9B2Y	CEFPROZIL TABLET, FILM COATED CEFPROZIL POWDER, FOR SUSPENSION [SANDOZ INC]	11
POLYETHYLENE GLYCOL 400	INACTIVE INGREDIENT	B697894SGQ	CEFPROZIL TABLET, FILM COATED CEFPROZIL POWDER, FOR SUSPENSION [SANDOZ INC]	11
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	CEFPROZIL TABLET, FILM COATED CEFPROZIL POWDER, FOR SUSPENSION [SANDOZ INC]	11
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	CEFPROZIL TABLET, FILM COATED CEFPROZIL POWDER, FOR SUSPENSION [SANDOZ INC]	11
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	CEFPROZIL TABLET, FILM COATED CEFPROZIL POWDER, FOR SUSPENSION [SANDOZ INC]	11
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	CEFPROZIL TABLET, FILM COATED CEFPROZIL POWDER, FOR SUSPENSION [SANDOZ INC]	11
SODIUM CHLORIDE	INACTIVE INGREDIENT	451W47IQ8X	CEFPROZIL TABLET, FILM COATED CEFPROZIL POWDER, FOR SUSPENSION [SANDOZ INC]	11
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	CEFPROZIL TABLET, FILM COATED CEFPROZIL POWDER, FOR SUSPENSION [SANDOZ INC]	11
SUCROSE	INACTIVE INGREDIENT	C151H8M554	CEFPROZIL TABLET, FILM COATED CEFPROZIL POWDER, FOR SUSPENSION [SANDOZ INC]	11
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	CEFPROZIL TABLET, FILM COATED CEFPROZIL POWDER, FOR SUSPENSION [SANDOZ INC]	11